GlassScriptPhysician profile
Jonel Dershem
NPI 1003988403
$2,193.20
in general payments reported to CMS, 2019-2025
28 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $457 · 2020: $219 · 2021: $817 · 2022: $539 · 2023: $161.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $85.00 · Food and Beverage: $76.31.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $85.00 |
| Food and Beverage | $76.31 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $459.26 | 2019-2023 | Evenity, Prolia |
| Abbvie INC. | $370.44 | 2019-2022 | |
| Ascend Therapeutics US, LLC | $195.01 | 2021 | |
| Astellas Pharma US INC | $194.62 | 2019-2023 | Myrbetriq |
| Pfizer INC. | $159.84 | 2020-2022 | |
| Therapeuticsmd, INC. | $117.73 | 2019-2022 | |
| Exeltis, USA INC. | $111.12 | 2019-2022 | |
| Agile Therapeutics, INC. | $80.57 | 2021-2022 | |
| Myovant Sciences INC. | $45.97 | 2022 | |
| Cumberland Pharmaceuticals, INC. | $45.42 | 2019-2021 | |
| Lupin INC. | $42.87 | 2020 | |
| Avion Pharmaceuticals | $40.07 | 2019-2020 | |
| Bayer Healthcare Pharmaceuticals INC. | $32.88 | 2019-2021 | |
| Coopersurgical, INC. | $32.86 | 2023 | Endosee |
| Allergan, INC. | $27.87 | 2019-2020 |
Show all 28 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Evofem Biosciences, INC. | $26.94 | 2021 | |
| Mission Pharmacal Company | $26.70 | 2019 | |
| Daiichi Sankyo INC. | $26.26 | 2020 | |
| Merck Sharp & Dohme LLC | $25.50 | 2021-2022 | |
| Medtronic, INC. | $20.41 | 2022 | |
| Becton, Dickinson and Company | $19.85 | 2021 | |
| Hologic Sales and Service, LLC | $14.58 | 2019 | |
| Mayne Pharma Commercial LLC | $14.48 | 2022 | |
| Organon LLC | $14.40 | 2022 | |
| Duchesnay USA Incorporated | $12.40 | 2019 | |
| Mylan Pharmaceuticals INC. | $12.22 | 2022 | |
| Scynexis, INC. | $11.73 | 2022 | |
| Ferring Pharmaceuticals INC. | $11.20 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jonel Dershem listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.